Logo image of DPLO

DIPLOMAT PHARMACY INC (DPLO) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:DPLO -

4
+0.01 (+0.25%)
Last: 2/7/2020, 8:04:06 PM
4
0 (0%)
After Hours: 2/7/2020, 8:04:06 PM

DPLO Key Statistics, Chart & Performance

Key Statistics
Market Cap304.00M
Revenue(TTM)5.21B
Net Income(TTM)-649.07M
Shares76.00M
Float19.51M
52 Week High14.46
52 Week Low2.43
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.54
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
DPLO short term performance overview.The bars show the price performance of DPLO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

DPLO long term performance overview.The bars show the price performance of DPLO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of DPLO is 4 null. In the past month the price increased by 0.25%. In the past year, price decreased by -69.47%.

DIPLOMAT PHARMACY INC / DPLO Daily stock chart

DPLO Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to DPLO. When comparing the yearly performance of all stocks, DPLO is a bad performer in the overall market: 97.95% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DPLO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to DPLO. DPLO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DPLO Financial Highlights

Over the last trailing twelve months DPLO reported a non-GAAP Earnings per Share(EPS) of -0.5399999999999999. The EPS decreased by -198.18% compared to the year before.


Industry RankSector Rank
PM (TTM) -12.47%
ROA -55.83%
ROE N/A
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%-102178.26%
Sales Q2Q%-5.25%
EPS 1Y (TTM)-198.18%
Revenue 1Y (TTM)-1.53%

DPLO Forecast & Estimates


Analysts
Analysts56
Price TargetN/A
EPS Next Y-560%
Revenue Next YearN/A

DPLO Ownership

Ownership
Inst Owners83.92%
Ins Owners1.72%
Short Float %N/A
Short RatioN/A

About DPLO

Company Profile

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.

Company Info

DIPLOMAT PHARMACY INC

4100 S. SAGINAW ST.

FLINT MI 48507

CEO: Brian T. Griffin

Phone: 888-720-4450

DIPLOMAT PHARMACY INC / DPLO FAQ

What does DPLO do?

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.


What is the current price of DPLO stock?

The current stock price of DPLO is 4 null. The price increased by 0.25% in the last trading session.


Does DIPLOMAT PHARMACY INC pay dividends?

DPLO does not pay a dividend.


What is the ChartMill rating of DIPLOMAT PHARMACY INC stock?

DPLO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Which stock exchange lists DPLO stock?

DPLO stock is listed on the New York Stock Exchange exchange.


Can you provide the market cap for DIPLOMAT PHARMACY INC?

DIPLOMAT PHARMACY INC (DPLO) has a market capitalization of 304.00M null. This makes DPLO a Small Cap stock.